The DOI matches its Crossref record; 271 of the 271 references it cites were found in a registry or an index.
The role of the brain reward system in depression
Abstract
The goal of this review is to familiarize the reader about the potential involvement of the brain reward system (BRS) in symptoms of Major Depressive Disorder (MDD). The authors introduce a novel approach to study the pathophysiology of MDD that includes pharmacological probing of BRS pathways (e.g. d-amphetamine, hydromorphone) together with an elicited and measurable behavioral component (e.g. pleasant effects, increased energy, altered cognition). To this date, the major focus of MDD pathophysiology studies has been to characterize biological differences between healthy subjects and depressed patients such as alteration in the monoaminergic and endocrine systems. The relative importance of the various biological changes has not been elucidated, that is, linking these with specific behavioral manifestations in MDD have rarely been attempted. One core symptom of MDD is a decreased experience of pleasure or interest in previously enjoyed activities (i.e. anhedonia) such as work or hobbies, and is accompanied by decreased motivation or drive. The BRS consists of the neural pathways involved in eliciting rewarding experiences in animals and humans. The hypothesis is that altered BRS function may be an underlying brain mechanism of the loss of pleasure/interest experienced in MDD, and will be manifested through an altered response to a BRS probe. The authors have examined BRS function in MDD by introducing a pharmacological probe (i.e. d-amphetamine/d-amph). Amphetamine is defined as a probe due to its ability to release dopamine within major components of the BRS (i.e. the mesocorticolimbic dopamine system.) In addition to the objective pharmacological effects (e.g. altered heart rate), BRS probes like d-amph elicit reliable and measurable behavior, that is, the hedonic effects. A review of the neurobiology of MDD, the BRS, the rationale for implicating the BRS in depressive symptoms, and preliminary data, are presented in this article.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“These systems play key roles in neurotransmission, brain maturation, cortical organisation and behaviours (including social behaviour and repetitive behaviour) [180,181,182,183,184].”
From Vitamin D and Autism Spectrum Disorder: A Literature Review (2016) · cites this paper as [182]
In the citing paper
“Multiple lines of evidence suggest an involvement of dysregulated neurotransmitter systems (serotonergic, oxytocinergic and dopaminergic systems) in autism.”
From Vitamin D and Autism Spectrum Disorder: A Literature Review (2016) · cites this paper as [182]
Citations
Cites
Items 201–271 of 271
Cocaine Is Self‐administered into the Shell Region of the Nucleus Accumbens in Wistar Rats
McKinzie, D. L., Rodd, Z. A., DAGON, C. T., MURPHY, J. M., & McBride, W. J. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09323.x · Cited by 54
Ramsey, N. F., & van Ree, J. M. (1991) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(91)90090-o · Cited by 54
Attenuation of some subjective effects of amphetamine following tyrosine depletion
McTavish, S. F. B., McPherson, M. H., Sharp, T., & Cowen, P. J. (1999) · Journal of Psychopharmacology · doi:10.1177/026988119901300205 · Cited by 53
Regulation of Neurotransmitter Interactions in the Ventral Striatum
McGinty, J. F. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09265.x · Cited by 53
Re-evaluation of the role of dopamine in intracranial self-stimulation using in vivo microdialysis
Miliaressis, E., Émond, C., & Merali, Z. (1991) · Behavioural Brain Research · doi:10.1016/s0166-4328(05)80095-6 · Cited by 52
Berridge, K. C. (1989) · Psychobiology · doi:10.3758/bf03337797 · Cited by 52
Mesolimbic Neuronal Activity across Behavioral States
Woodward, D. J., CHANG, J., Janak, P. H., Azarov, A. V., & Anstrom, K. K. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09263.x · Cited by 50
Cabib, S., Puglisi‐Allegra, S., Genua, C., Simon, H., Moal, M. L., & Piazza, P. V. (1996) · Psychopharmacology · doi:10.1007/bf02247398 · Cited by 49
"Compendium of pharmaceuticals and specialties".
Geekie, D. A. (1977) · PubMed · Cited by 47
Nürnberger, J. I., Simmons-Alling, S., Kessler, L. R., Jimerson, S. S., Schreiber, J. G., Hollander, E., Tamminga, C. A., Nadi, N. S., Goldstein, D. S., & Gershon, E. S. (1984) · Psychopharmacology · doi:10.1007/bf00427446 · Cited by 47
Zangen, A., Nakash, R., & Yadid, G. (1999) · Journal of Neurochemistry · doi:10.1046/j.1471-4159.1999.0732569.x · Cited by 46
Little, J. T., Ketter, T. A., Kimbrell, T. A., Danielson, A., Benson, B., Willis, M. W., & Post, R. M. (1996) · PubMed · Cited by 45
Fletcher, P. J. (1995) · Psychopharmacology · doi:10.1007/bf02245834 · Cited by 45
Foltin, R. W., & Fischman, M. W. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01758.x · Cited by 44
Changes in pupil reaction to light in melancholic patients
Fountoulakis, K. Ν., Fotiou, F., Iacovides, A., Tsiptsios, J., Goulas, A., Tsolaki, M., & Ierodiakonou, C. S. (1999) · International Journal of Psychophysiology · doi:10.1016/s0167-8760(98)00046-4 · Cited by 44
Time-Dependent Alterations in ICSS Thresholds Associated With Repeated Amphetamine Administrations
Lin, D. C.-H. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00213-0 · Cited by 44
Sampson, D., Muscat, R., Phillips, G. D., & Willner, P. (1992) · Neuroscience & Biobehavioral Reviews · doi:10.1016/s0149-7634(05)80193-9 · Cited by 43
Rational Drug Use in the Treatment of Depression
Cohen, L. J. (1997) · Pharmacotherapy The Journal of Human Pharmacology and Drug Therapy · doi:10.1002/j.1875-9114.1997.tb03677.x · Cited by 42
Vigilance Performance in Parkinson's Disease and Depression
Hart, R. P., Wade, J. B., Calabrese, V. P., & Colenda, C. C. (1998) · Journal of Clinical and Experimental Neuropsychology · doi:10.1076/1380-3395(199802)20:1;1-p;ft111 · Cited by 42
Kling-Petersen, T., Ljung, E., Wollter, L., & Svensson, K. A. (1995) · Journal of Neural Transmission · doi:10.1007/bf01271543 · Cited by 40
Are all antidepressants the same?
Möller, H. (2000) · PubMed · Cited by 40
Stimulus effects of d-Amphetamine II: DA, NE, and 5-HT mechanisms
West, W. B. (1995) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(94)00361-l · Cited by 39
Hédou, G., Homberg, J. R., Martı́n, S., Wirth, K., Feldon, J., & Heidbreder, C. A. (2000) · European Journal of Pharmacology · doi:10.1016/s0014-2999(00)00038-8 · Cited by 38
Effects of chronic naloxone treatment on brain-stimulation reward
Perry, W., Esposito, R., & Kornetsky, C. H. (1981) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(81)90251-3 · Cited by 37
Parekh, P. I., Ketter, T. A., Altshuler, L. L., Frye, M. A., Callahan, A., Marangell, L. B., & Post, R. M. (1998) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00513-1 · Cited by 36
Opioid regulation of hypothalamic-pituitary-adrenal function in depression.
Zis, A. P., Haskett, R., Albala, A., Carroll, B. J., & Lohr, N. (1985) · Archives of General Psychiatry · doi:10.1001/archpsyc.1985.01790270073008 · Cited by 36
Ward, A. S., Collins, E. D., Haney, M., Foltin, R. W., & Fischman, M. W. (1998) · Behavioural Pharmacology · doi:10.1097/00008877-199811000-00013 · Cited by 35
Burnett, F., Scott, L. V., Weaver, M. G., Medbak, S., & Dinan, T. G. (1999) · Journal of Affective Disorders · doi:10.1016/s0165-0327(98)00127-x · Cited by 35
Anhedonie - nosologieübergreifendes Korrelat einer Dysfunktion des dopaminergen Verstärkungssystems?
Heinz, A. (1999) · Der Nervenarzt · doi:10.1007/s001150050454 · Cited by 34
History of abuse liability testing in humans
Jasinski, D. R. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01748.x · Cited by 34
Drug self‐administration methods in abuse liability evaluation
Henningfield, J. E., Cohen, C., & Heishman, S. J. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01750.x · Cited by 34
Grady, T. A., Broocks, A., Canter, S. K., Pigott, T. A., Dubbert, B. K., Hill, J., & Murphy, D. L. (1996) · Psychiatry Research · doi:10.1016/0165-1781(96)02884-3 · Cited by 33
Roache, J. D., & Griffiths, R. R. (1989) · Psychopharmacology · doi:10.1007/bf00445549 · Cited by 33
West, C. H. K., Bonsall, R. W., Emery, M., & Weiss, J. M. (1999) · Psychopharmacology · doi:10.1007/s002130051113 · Cited by 33
The neuroendocrine and behavioral response to dextroamphetamine in normal individuals.
Dommisse, C. S., Schulz, S. C., Narasimhachari, N., Blackard, W. G., & Hamer, R. M. (1984) · PubMed · Cited by 33
Methylphenidate Hydrochloride as an Antidepressant: Controversy, Case Studies, and Review
Kraus, M. F., & BURCH, E. A. (1992) · Southern Medical Journal · doi:10.1097/00007611-199210000-00012 · Cited by 31
Abuse liability assessment of anxiolytics/ hypnotics: rationale and laboratory lore
Evans, S. M., Critchfield, T. S., & Griffiths, R. R. (1991) · British Journal of Addiction · doi:10.1111/j.1360-0443.1991.tb01757.x · Cited by 31
A Dopamine D1 Agonist Elevates Self-Stimulation Thresholds
Baldo, B. A., Jain, K., Veraldi, L., Koob, G. F., & Markou, A. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00206-8 · Cited by 30
Phenylpropanolamine: reinforcing and subjective effects in normal human volunteers
Chait, L. D., UHLENHUTH, E. H., & Johanson, C. E. (1988) · Psychopharmacology · doi:10.1007/bf00177562 · Cited by 30
Parkinsonian patients report blunted subjective effects of methylphenidate.
Persico, A. M., Reich, S., Henningfield, J. E., Kuhar, M. J., & Uhl, G. R. (1998) · Experimental and Clinical Psychopharmacology · doi:10.1037/1064-1297.6.1.54 · Cited by 30
Besson, A., Privat, A. M., Eschalier, A., & Fialip, J. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00102-1 · Cited by 30
Evaluation of linkage of markers on chromosome 6p with schizophrenia in Taiwanese families
Hwu, H., Lin, M., Lee, P.-C., Lee, S. F. ‐., Ouyang, W., & Liu, C. (2000) · American Journal of Medical Genetics · doi:10.1002/(sici)1096-8628(20000207)96:1 · Cited by 30
Jh, J., & Jaffe, F. K. (1989) · PubMed · Cited by 29
Clinical applications of functional MRI in neuropsychiatry
Levin, J. M., Ross, M. H., & Renshaw, P. F. (1995) · Journal of Neuropsychiatry · doi:10.1176/jnp.7.4.511 · Cited by 29
Posttraumatic Stress and Depression
Petty, F., Kramer, G. L., WU, J., & Davis, L. L. (1997) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1997.tb48322.x · Cited by 28
Measurement of reinforcement in depression: A pilot study
Hughes, J. R., Pleasants, C. N., & Pickens, R. W. (1985) · Journal of Behavior Therapy and Experimental Psychiatry · doi:10.1016/0005-7916(85)90068-0 · Cited by 28
Panos, J., Rademacher, D. J., Renner, S. L., & Steinpreis, R. E. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00155-0 · Cited by 27
Comer, S. D., Haney, M., Foltin, R. W., & Fischman, M. W. (1996) · Psychopharmacology · doi:10.1007/bf02805973 · Cited by 26
Muñoz, C., & Papp, M. (1999) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00031-3 · Cited by 26
Ward, A. S., Collins, E. D., Haney, M., Foltin, R. W., & Fischman, M. W. (1999) · Behavioural Pharmacology · doi:10.1097/00008877-199909000-00010 · Cited by 24
Amphetamine, but Not Methylphenidate, Predicts Antidepressant Efficacy
Little, K. Y. (1988) · Journal of Clinical Psychopharmacology · doi:10.1097/00004714-198806000-00004 · Cited by 24
The reinforcing properties of amphetamine in overweight subjects and subjects with depression
de Wit, H., UHLENHUTH, E. H., & Johanson, C. E. (1987) · Clinical Pharmacology & Therapeutics · doi:10.1038/clpt.1987.122 · Cited by 24
Nicotine and Endogenous Opioids: Toward Specific Pharmacotherapy
Ismail, Z., & el‐Guebaly, N. (1998) · The Canadian Journal of Psychiatry · doi:10.1177/070674379804300103 · Cited by 23
Involvement of Acetylcholine in the Nucleus Accumbens in Cocaine Reinforcement
Mark, G. P., Kinney, A. E. “., Grubb, M. C., & Keys, A. S. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09324.x · Cited by 21
Reversal of Learned Helplessness by Morphine in Rats Involvement of a Dopamine Mediation
Besson, A. (1998) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(98)00002-1 · Cited by 20
Catecholamines and endogeneous opioids in ventral tegmental self-stimulation reward
van Wolfswinkel, L., Seifert, W. F., & van Ree, J. M. (1988) · Pharmacology Biochemistry and Behavior · doi:10.1016/0091-3057(88)90070-6 · Cited by 19
A role for AMPA/kainate receptors in conditioned place preference induced by diazepam in the rat
Gray, A. M., Allison, C., & Pratt, J. A. (1999) · Neuroscience Letters · doi:10.1016/s0304-3940(99)00371-7 · Cited by 19
Sexual motivation: involvement of endogenous opioids in the ventral tegmental area
van Furth, W. (1996) · Brain Research · doi:10.1016/s0006-8993(96)00225-9 · Cited by 19
Predicting the dependence liability of stimulant drugs.
Griffiths, R. R., Jv, B., & Bigelow, G. E. (1981) · PubMed · Cited by 19
Ikemoto, S., & Goeders, N. E. (2000) · Brain Research Bulletin · doi:10.1016/s0361-9230(99)00214-2 · Cited by 17
Michelson, D. (1996) · Neuropsychopharmacology · doi:10.1016/0893-133x(95)00210-5 · Cited by 17
Leavitt, F. J., & Labott, S. M. (1998) · Journal of Clinical Psychology · doi:10.1002/(sici)1097-4679(199810)54:6 · Cited by 16
Hédou, G., Homberg, J. R., Feldon, J., & Heidbreder, C. A. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09331.x · Cited by 16
Powell, K. R., & Holtzman, S. G. (2000) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(99)00183-5 · Cited by 16
Bush, D. E. A., DeSousa, N. J., & Vaccarino, F. J. (1999) · Psychopharmacology · doi:10.1007/s002130051176 · Cited by 15
Sziráki, I., Sershen, H. W., Benuck, M., Hashim, A., & Lajtha, Á. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09326.x · Cited by 15
Fabian, J., & Silverstone, P. H. (1997) · International Clinical Psychopharmacology · doi:10.1097/00004850-199703000-00007 · Cited by 13
Modeling Drug Dependence Behaviors for Animal and Human Studies
Hughes, J. R., & Bickel, W. K. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(96)00443-1 · Cited by 11
Glautier, S., Bankart, J., Rigney, U., & Willner, P. (1998) · Behavioural Pharmacology · doi:10.1097/00008877-199811000-00017 · Cited by 11
Amphetamine Injections into the Nucleus Accumbens Enhance the Reward of Stimulation of the Subiculum
SWEET, K. L., & Neill, D. B. (1999) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1999.tb09332.x · Cited by 8
Jaffe, J. H., & Jaffe, F. K. (1989) · PsycEXTRA Dataset · doi:10.1037/e496492006-007 · Cited by 8
Research works printed but not linked: 7
- 1999, Guidelines for the Diagnosis and Pharmacological Treatment of Depression
- Cardenas, 2000, Dopaminergic activity in depressed smokers, Br. J. Clin. Pharmacol., 425
- Herbrener, 2000, Anhedonia in schizophrenia: Longitudinal Analyses, American Psychiatric Association Conference. Conference Proceeding
- Jasinski, 1989, Human abuse liability assesment by measurement of subjective and physiological effects. Testing for abuse liability of drugs in humans, NIDA Res. Monogr., 93, 73
- Segal, 1996, Biobehavioral effects of psychoactive drugs (Chapter 16). In Neurobehavioural toxicology and addiction, 451
- Tremblay, 2000, Response to d-amphetamine is altered in Major Depressive Disorder (MDD), Clin. Pharmacol. Ther., 67, 130
- Tremblay, 2000, Probing the Brain Reward System in Major Depressive Disorder: Altered response to d-amphetamine
Cited by
Sorted by citations
The Neural Correlates of Anhedonia in Major Depressive Disorder
Keedwell, P. A., Andrew, C., Williams, S. C. R., Brammer, M. J., & Phillips, M. L. (2005) · Biological Psychiatry · doi:10.1016/j.biopsych.2005.05.019 · Cited by 650
Carver, C. S., Johnson, S. L., & Joormann, J. (2008) · Psychological Bulletin · doi:10.1037/a0013740 · Cited by 510
Lack of Ventral Striatal Response to Positive Stimuli in Depressed Versus Normal Subjects
Epstein, J., Pan, H., Kocsis, J. H., Yang, Y., Butler, T., Chusid, J., Hochberg, H., Murrough, J., Strohmayer, E., Stern, E., et al. (2006) · American Journal of Psychiatry · doi:10.1176/ajp.2006.163.10.1784 · Cited by 464
Pryce, C. R., Rüedi‐Bettschen, D., Dettling, A. C., Weston, A. A., Russig, H., Ferger, B., & Feldon, J. (2005) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2005.03.011 · Cited by 430
Zhang, W.-N., Chang, S.-H., Guo, L.-Y., Zhang, K.-L., & Wang, J. (2013) · Journal of Affective Disorders · doi:10.1016/j.jad.2013.06.039 · Cited by 355
Metadata
- Authors
- Naranjo, C. A., Tremblay, L. K., & Busto, U. E.
- Affiliations
- Sunnybrook Health Science Centre (CA)
- Corresponding author
- Naranjo, Claudio A.
- Venue
- Progress in Neuro-Psychopharmacology and Biological Psychiatry
- Publisher
- Elsevier BV
- Published
- 2001-05
- Volume
- 25
- Issue
- 4
- Pages
- 781-823
- ISSN
- 0278-5846 (ISSN-L)
- OpenAlex
- W2040295810
- Cited by
- 245
- References
- 271
- Citations by year
- 2025: 7 · 2024: 5 · 2023: 3 · 2022: 6 · 2021: 7 · 2020: 7 · 2019: 9 · 2018: 13 · 2017: 11 · 2016: 10 · 2015: 8 · 2014: 7 · 2013: 13 · 2012: 13
- FWCI
- 0.77
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Progress in Neuro-Psychopharmacology and Biological Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Neurotransmitter Receptor Influence on Behavior
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Life Sciences › Neuroscience › Cognitive Neuroscience › Neural and Behavioral Psychology Studies
- Keywords
- brain reward system, major depressive disorder, anhedonia, dopamine, mesocorticolimbic dopamine system, amphetamine challenge, hydromorphone, motivation, depression pathophysiology
- MeSH terms
- Amphetamine, Central Nervous System Stimulants, Animals, Brain, Brain Chemistry, Depressive Disorder, Humans, Reward
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review